JP2013505251A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505251A5
JP2013505251A5 JP2012529897A JP2012529897A JP2013505251A5 JP 2013505251 A5 JP2013505251 A5 JP 2013505251A5 JP 2012529897 A JP2012529897 A JP 2012529897A JP 2012529897 A JP2012529897 A JP 2012529897A JP 2013505251 A5 JP2013505251 A5 JP 2013505251A5
Authority
JP
Japan
Prior art keywords
implant
kit
different
implant device
sites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012529897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505251A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/049104 external-priority patent/WO2011035013A2/en
Publication of JP2013505251A publication Critical patent/JP2013505251A/ja
Publication of JP2013505251A5 publication Critical patent/JP2013505251A5/ja
Pending legal-status Critical Current

Links

JP2012529897A 2009-09-17 2010-09-16 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法 Pending JP2013505251A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24330309P 2009-09-17 2009-09-17
US61/243,303 2009-09-17
PCT/US2010/049104 WO2011035013A2 (en) 2009-09-17 2010-09-16 Implant devices that differ by release profile and methods of making and using same

Publications (2)

Publication Number Publication Date
JP2013505251A JP2013505251A (ja) 2013-02-14
JP2013505251A5 true JP2013505251A5 (enExample) 2013-11-07

Family

ID=43218276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529897A Pending JP2013505251A (ja) 2009-09-17 2010-09-16 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法

Country Status (10)

Country Link
US (1) US9399018B2 (enExample)
EP (1) EP2477612A2 (enExample)
JP (1) JP2013505251A (enExample)
KR (1) KR20120102598A (enExample)
CN (1) CN102917693B (enExample)
BR (1) BR112012006103B8 (enExample)
CA (1) CA2774495C (enExample)
IN (1) IN2012DN02656A (enExample)
RU (1) RU2012115120A (enExample)
WO (1) WO2011035013A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781264B1 (en) 2004-08-04 2013-07-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
EP2480200A2 (en) * 2009-09-22 2012-08-01 Evonik Degussa Corporation Implant devices having varying bioactive agent loading configurations
US9980850B2 (en) 2016-09-29 2018-05-29 Gesea Biosciences, Inc. Bioerodible contraceptive implant and methods of use thereof
KR102183669B1 (ko) * 2019-03-26 2020-11-26 가톨릭대학교 산학협력단 이중 약물 방출을 위한 약물 전달체
JP6905035B2 (ja) 2019-11-29 2021-07-21 Ｎｉｓｓｈａ株式会社 可食性フィルムの製造方法、フィルム製剤及び可食性フィルム

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US4720384A (en) * 1985-05-03 1988-01-19 E. I. Du Pont De Nemours And Company Manufacture of hollow fine tubular drug delivery systems
US4976949A (en) * 1985-10-25 1990-12-11 The University Of Michigan Controlled release dosage form
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
JPS63203610A (ja) * 1987-02-12 1988-08-23 ヘキスト・アクチエンゲゼルシヤフト 複数成分からなるインプラント用の持効性医薬製剤
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
JP2702729B2 (ja) * 1988-02-24 1998-01-26 エーザイ株式会社 徐放性埋込剤
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5178874A (en) * 1989-06-30 1993-01-12 Smithkline Beechman Corporation Intermittent release dosage form
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
JP3118009B2 (ja) 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US6447796B1 (en) * 1994-05-16 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US6855331B2 (en) * 1994-05-16 2005-02-15 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US6902743B1 (en) * 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US5705191A (en) * 1995-08-18 1998-01-06 The United States Of America As Represented By The Secretary Of The Navy Sustained delivery of active compounds from tubules, with rational control
EP1001743B1 (fr) * 1997-06-04 2006-02-01 Debio Recherche Pharmaceutique S.A. Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication
DE69819351D1 (de) * 1997-09-11 2003-12-04 Nycomed Danmark As Roskilde Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
US6296831B1 (en) * 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
DE69940735D1 (de) * 1998-07-17 2009-05-28 Pacira Pharmaceuticals Inc Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU6326000A (en) * 1999-07-26 2001-02-13 Bomac Laboratories Limited Improvements in dispensing vaccines
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
KR20020072290A (ko) * 2000-01-20 2002-09-14 델시스 파머수티컬 코포레이션 다단계 약물 투여 형태
US6479065B2 (en) * 2000-08-10 2002-11-12 Alkermes Controlled Therapeutics, Inc. Process for the preparation of polymer-based sustained release compositions
US20030055075A1 (en) 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
NZ519363A (en) * 2002-06-05 2004-02-27 Agres Ltd A novel drug dosing regimen
US7101566B2 (en) 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
US7220433B2 (en) * 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8685435B2 (en) * 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
WO2005107715A1 (en) * 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
EP1781264B1 (en) 2004-08-04 2013-07-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
CN101163464A (zh) * 2004-12-23 2008-04-16 杜雷科特公司 优选含有PEG和PLG混合物的控制释放GnRH的聚合物植入物
US8969415B2 (en) * 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems

Similar Documents

Publication Publication Date Title
Liu et al. Synthesis, preparation, in vitro degradation, and application of novel degradable bioelastomers—A review
WO2009058990A3 (en) Vascular closure device
JP2013505251A5 (enExample)
WO2010005723A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
JP2017080618A5 (enExample)
WO2012034049A3 (en) Implantable medical devices having double walled microspheres
EP3861982A3 (en) Intracameral implant for treatment of an ocular condition
BRPI0810899A2 (pt) Formulação de nanopartículas de plga ativadas carregadas com agente ativo para substâncias nano-terapêuticas anticâncer direcionais.
EP2644114A3 (en) Layered tissue thickness compensator
CY1119829T1 (el) Βιοαποικοδομησιμες συνθεσεις απελευθερωσης φαρμακου
WO2012166923A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
EP2406262A4 (en) PRODRUG FORMS OF KINASEHEMMERN AND THEIR USE IN THERAPY
BRPI0920314A2 (pt) dispositivo médico com liberação controlada de agente antibacteriano
WO2009029958A3 (en) Implantable delivery device
FR2930553B1 (fr) Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
DK2281576T3 (da) Aktiv målsøgende polymermicelle med deri indkapslet medikament samt medicinsk sammensætning
WO2011080141A3 (en) Degradable removable implant for the sustained release of an active compound
NZ604342A (en) Antipsychotic injectable depot composition
WO2014106116A8 (en) Therapeutic compositions comprising antibodies
ZA200900929B (en) Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
WO2010118213A3 (en) Particles for delivery of nucleic acids and related devices and methods
MX2015008286A (es) Composiciones multipolimericas para liberación transdermica de farmaco.